anti-CD99 diabody (Diatheva)

N/A

Report date: 2025/01/26 18:41:13

Base Information

Drug Nameanti-CD99 diabody (Diatheva)
Drug Alias NameC-7
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionCD99 antigen modulators
TargetsCD99 antigen
Therapy Area/IndicationsSarcoma, Ewing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDiatheva srl
China Registration ClassN/A

Develop Information

Active CompaniesDiatheva srl
Inactive CompaniesN/A
Active IndicationsSarcoma, Ewing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A